Literature DB >> 20615742

Suspected oseltamivir-induced bradycardia.

R Karplus, S Sanset, R Zaidenstein, D Schneider, M Berkovitch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20615742     DOI： 10.1016/j.ijid.2010.03.009

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN： 1201-9712            Impact factor:   3.623


× No keyword cloud information.
  4 in total

1.  The anti-influenza drug oseltamivir reduces atrial fibrillation in an experimental whole-heart model.

Authors:  Gerrit Frommeyer; André Mittelstedt; Julian Wolfes; Christian Ellermann; Simon Kochhäuser; Patrick Leitz; Dirk G Dechering; Lars Eckardt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-08-06       Impact factor: 3.000

2.  High-Grade Atrioventricular Block Associated With Acute Influenza.

Authors:  Kevin Ergle; Janelle Y Gooden; Mustafa M Ahmed
Journal:  Tex Heart Inst J       Date:  2020-06-01

3.  Case report on alimentary tract hemorrhage and liver injury after therapy with oseltamivir: A case report.

Authors:  Shengbo Fang; Lingli Qi; Na Zhou; Chunyan Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

Review 4.  Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.

Authors:  James R Smith; Craig R Rayner; Barbara Donner; Martina Wollenhaupt; Klaus Klumpp; Regina Dutkowski
Journal:  Adv Ther       Date:  2011-11-01       Impact factor: 3.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.